drugset / Trial / NCT01113333
Safety, Tolerability and Pharmacokinetics of SAR113945 Following Intra-articular Administration in Patients With Knee Osteoarthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
Primary Objective: * Assess the safety and tolerability of single intra-articular doses of SAR113945 in patients with knee osteoarthritis. Secondary Objective: * Assess systemic exposure of SAR113945 following intra-articular delivery.
Timeline
- Start
- 2010-04
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAR113945 | Unknown | — | Other |